AgEagle Aerial Systems Rebrands as EagleNXT to Drive Next Phase of Growth and Innovation

Stock Information for Oncternal Therapeutics Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Oncternal Therapeutics Inc.

EagleNXT Highlights Key 2025 Achievements Across Defense, Innovation, Global Expansion, and Capital Flexibility, Provides 2026 Growth Outlook
EagleNXT MicaSense Cameras Now Compatible with Inspired Flight Technologies (IFT) new "Dovetail" Mount
EagleNXT Commences Deliveries with Vyom Drones to Serve India's Growing Unmanned Vehicle Demands
EagleNXT Reports Third Quarter Fiscal Year 2025 Financial Results and Highlights Key Operational Developments
EagleNXT Achieves ANATEL Certification Renewal for eBee X Drone Operations in Brazil 
AgEagle Aerial Systems Inc Announces Entry to Purchases Sales Agreement up to $100,000,000 Series G
Commercial UAV Market Expected to Reach $7.64 Trillion By 2034 as Global Growth Outlook is Strong
EagleNXT Announces Sale of eBee VISION Drones to U.S. Army's 1st Battalion, 4th Infantry Regiment in Germany

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.